Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocuphire Pharma, Inc. - Common Stock
(NQ:
OCUP
)
1.170
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocuphire Pharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
↗
October 23, 2024
Ocuphire Pharma acquires Opus Genetics, expanding its IRD gene therapy pipeline. The renamed company, Opus Genetics, will trade under "IRD" by late October 2024.
Via
Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders
October 23, 2024
From
Ademi LLP
Via
Business Wire
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
↗
August 13, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
↗
June 14, 2024
These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist.
Via
Talk Markets
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
↗
May 22, 2024
Via
Benzinga
Recap: Ocuphire Pharma Q3 Earnings
↗
November 13, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
↗
May 22, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
May 01, 2023
Via
Benzinga
Ocuphire Pharma Inc. (NASDAQ: OCUP) Highlighted for Surprising Price Action
April 04, 2023
Via
Investor Brand Network
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024
↗
May 10, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 11, 2024
Via
Benzinga
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
↗
March 26, 2024
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023
↗
March 15, 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
↗
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
3 Value Stocks to Buy on the Dip: February 2024
↗
February 07, 2024
While many investors continue to chase after the latest trends, these underappreciated value stocks to buy could be the true winners.
Via
InvestorPlace
Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024
↗
November 30, 2023
Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.
Via
InvestorPlace
A Look Into Healthcare Sector Value Stocks
↗
November 20, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
November 06, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
September 11, 2023
Via
Benzinga
Surprise! These 3 Penny Stocks Pack Powerful Financials.
↗
July 10, 2023
While investing in penny stocks carries a rough reputation (to put it nicely), these speculative entities just might surprise you.
Via
InvestorPlace
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
The 7 Best Stocks Under $10 to Buy in May
↗
May 03, 2023
While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.
Via
InvestorPlace
7 Small-Cap Biotech Stocks with Massive Potential
↗
April 27, 2023
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
Via
InvestorPlace
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
↗
April 21, 2023
Ocuphire Pharma Inc (NASDAQ: OCUP) was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CEO.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
↗
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
↗
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 04, 2023
Via
Benzinga
Ocuphire Pharma, Inc. (NASDAQ: OCUP) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
February 22, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
